Thc Biomed Intl Stock Price Prediction
| THCBF Stock | USD 0 0.00 0.00% |
Oversold Vs Overbought
19
Oversold | Overbought |
Using THC Biomed hype-based prediction, you can estimate the value of THC Biomed Intl from the perspective of THC Biomed response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in THC Biomed to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying THC because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
THC Biomed after-hype prediction price | USD 7.57E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
THC |
THC Biomed After-Hype Price Prediction Density Analysis
As far as predicting the price of THC Biomed at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in THC Biomed or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of THC Biomed, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
THC Biomed Estimiated After-Hype Price Volatility
In the context of predicting THC Biomed's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on THC Biomed's historical news coverage. THC Biomed's after-hype downside and upside margins for the prediction period are 0.00 and 32.99, respectively. We have considered THC Biomed's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
THC Biomed is out of control at this time. Analysis and calculation of next after-hype price of THC Biomed Intl is based on 3 months time horizon.
THC Biomed Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as THC Biomed is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading THC Biomed backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with THC Biomed, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
3.12 | 32.99 | 0.00 | 0.07 | 0 Events / Month | 5 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0 | 0.0008 | 24.27 |
|
THC Biomed Hype Timeline
THC Biomed Intl is at this time traded for 0. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.07. THC is forecasted to decline in value after the next headline, with the price expected to drop to 7.57E-4. The average volatility of media hype impact on the company price is insignificant. The price reduction on the next news is expected to be -24.27%, whereas the daily expected return is at this time at 3.12%. The volatility of related hype on THC Biomed is about 138905.26%, with the expected price after the next announcement by competition of 0.07. About 29.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.73. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. THC Biomed Intl recorded a loss per share of 0.02. The entity had not issued any dividends in recent years. Assuming the 90 days horizon the next forecasted press release will be within a week. Check out THC Biomed Basic Forecasting Models to cross-verify your projections.THC Biomed Related Hype Analysis
Having access to credible news sources related to THC Biomed's direct competition is more important than ever and may enhance your ability to predict THC Biomed's future price movements. Getting to know how THC Biomed's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how THC Biomed may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RZLT | Rezolute | 0.18 | 8 per month | 3.11 | 0.04 | 6.81 | (5.54) | 30.01 | |
| TPST | Tempest Therapeutics | (0.47) | 4 per month | 0.00 | (0.14) | 6.38 | (8.53) | 29.55 | |
| FBRX | Forte Biosciences | 0.19 | 4 per month | 3.42 | 0.10 | 6.65 | (6.33) | 113.07 | |
| DYAI | Dyadic International | 0.09 | 6 per month | 3.69 | 0.1 | 9.00 | (7.20) | 16.89 | |
| DMAC | DiaMedica Therapeutics | 0.16 | 5 per month | 2.11 | 0.05 | 4.94 | (3.29) | 10.25 | |
| SILO | Silo Pharma | 0.00 | 0 per month | 0.00 | (0.13) | 6.31 | (10.57) | 23.28 | |
| MOLN | Molecular Partners AG | (0.10) | 5 per month | 0.00 | (0.03) | 9.61 | (8.53) | 52.92 | |
| MLYS | Mineralys Therapeutics, Common | 0.14 | 8 per month | 3.37 | 0.03 | 6.27 | (5.79) | 20.98 |
THC Biomed Additional Predictive Modules
Most predictive techniques to examine THC price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for THC using various technical indicators. When you analyze THC charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About THC Biomed Predictive Indicators
The successful prediction of THC Biomed stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as THC Biomed Intl, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of THC Biomed based on analysis of THC Biomed hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to THC Biomed's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to THC Biomed's related companies.
Story Coverage note for THC Biomed
The number of cover stories for THC Biomed depends on current market conditions and THC Biomed's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that THC Biomed is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about THC Biomed's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
THC Biomed Short Properties
THC Biomed's future price predictability will typically decrease when THC Biomed's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of THC Biomed Intl often depends not only on the future outlook of the potential THC Biomed's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. THC Biomed's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 163.9 M |
Complementary Tools for THC Pink Sheet analysis
When running THC Biomed's price analysis, check to measure THC Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy THC Biomed is operating at the current time. Most of THC Biomed's value examination focuses on studying past and present price action to predict the probability of THC Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move THC Biomed's price. Additionally, you may evaluate how the addition of THC Biomed to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |